Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

NCT04461457 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT04461457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04461457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
Lead sponsor
Vastra Gotaland Region
Phase
Phase 1
Overall status
Completed
Start date
February 5, 2005
Completion date
January 19, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer